Drugs Used in Circadian Sleep-Wake Rhythm Disturbances

Helen J. Burgess, Jonathan Emens

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

This article focuses on melatonin and other melatonin receptor agonists, and specifically their circadian phase shifting and sleep-enhancing properties. The circadian system and circadian rhythm sleep-wake disorders are briefly reviewed, followed by a summary of the circadian phase shifting, sleep-enhancing properties, and possible safety concerns associated with melatonin and other melatonin receptor agonists. The recommended use of melatonin, including dose and timing, in the latest American Academy of Sleep Medicine Clinical Practice Guidelines for the treatment of intrinsic circadian rhythm disorders is also reviewed. Lastly, the practical aspects of treatment and consideration of clinical treatment outcomes are discussed.

Original languageEnglish (US)
Pages (from-to)231-241
Number of pages11
JournalSleep Medicine Clinics
Volume13
Issue number2
DOIs
StatePublished - Jun 1 2018

Fingerprint

Melatonin
Melatonin Receptors
Sleep
Chronobiology Disorders
Circadian Rhythm Sleep Disorders
Pharmaceutical Preparations
Clinical Medicine
Practice Guidelines
Safety
Therapeutics

Keywords

  • Advance
  • Agonist
  • Circadian
  • Delay
  • Melatonin
  • Shift
  • Sleep

ASJC Scopus subject areas

  • Neuropsychology and Physiological Psychology
  • Clinical Psychology
  • Clinical Neurology
  • Psychiatry and Mental health

Cite this

Drugs Used in Circadian Sleep-Wake Rhythm Disturbances. / Burgess, Helen J.; Emens, Jonathan.

In: Sleep Medicine Clinics, Vol. 13, No. 2, 01.06.2018, p. 231-241.

Research output: Contribution to journalReview article

Burgess, Helen J. ; Emens, Jonathan. / Drugs Used in Circadian Sleep-Wake Rhythm Disturbances. In: Sleep Medicine Clinics. 2018 ; Vol. 13, No. 2. pp. 231-241.
@article{b8ca3de7de204919afb058a20d45fd4a,
title = "Drugs Used in Circadian Sleep-Wake Rhythm Disturbances",
abstract = "This article focuses on melatonin and other melatonin receptor agonists, and specifically their circadian phase shifting and sleep-enhancing properties. The circadian system and circadian rhythm sleep-wake disorders are briefly reviewed, followed by a summary of the circadian phase shifting, sleep-enhancing properties, and possible safety concerns associated with melatonin and other melatonin receptor agonists. The recommended use of melatonin, including dose and timing, in the latest American Academy of Sleep Medicine Clinical Practice Guidelines for the treatment of intrinsic circadian rhythm disorders is also reviewed. Lastly, the practical aspects of treatment and consideration of clinical treatment outcomes are discussed.",
keywords = "Advance, Agonist, Circadian, Delay, Melatonin, Shift, Sleep",
author = "Burgess, {Helen J.} and Jonathan Emens",
year = "2018",
month = "6",
day = "1",
doi = "10.1016/j.jsmc.2018.02.006",
language = "English (US)",
volume = "13",
pages = "231--241",
journal = "Sleep Medicine Clinics",
issn = "1556-407X",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Drugs Used in Circadian Sleep-Wake Rhythm Disturbances

AU - Burgess, Helen J.

AU - Emens, Jonathan

PY - 2018/6/1

Y1 - 2018/6/1

N2 - This article focuses on melatonin and other melatonin receptor agonists, and specifically their circadian phase shifting and sleep-enhancing properties. The circadian system and circadian rhythm sleep-wake disorders are briefly reviewed, followed by a summary of the circadian phase shifting, sleep-enhancing properties, and possible safety concerns associated with melatonin and other melatonin receptor agonists. The recommended use of melatonin, including dose and timing, in the latest American Academy of Sleep Medicine Clinical Practice Guidelines for the treatment of intrinsic circadian rhythm disorders is also reviewed. Lastly, the practical aspects of treatment and consideration of clinical treatment outcomes are discussed.

AB - This article focuses on melatonin and other melatonin receptor agonists, and specifically their circadian phase shifting and sleep-enhancing properties. The circadian system and circadian rhythm sleep-wake disorders are briefly reviewed, followed by a summary of the circadian phase shifting, sleep-enhancing properties, and possible safety concerns associated with melatonin and other melatonin receptor agonists. The recommended use of melatonin, including dose and timing, in the latest American Academy of Sleep Medicine Clinical Practice Guidelines for the treatment of intrinsic circadian rhythm disorders is also reviewed. Lastly, the practical aspects of treatment and consideration of clinical treatment outcomes are discussed.

KW - Advance

KW - Agonist

KW - Circadian

KW - Delay

KW - Melatonin

KW - Shift

KW - Sleep

UR - http://www.scopus.com/inward/record.url?scp=85047161710&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047161710&partnerID=8YFLogxK

U2 - 10.1016/j.jsmc.2018.02.006

DO - 10.1016/j.jsmc.2018.02.006

M3 - Review article

C2 - 29759273

AN - SCOPUS:85047161710

VL - 13

SP - 231

EP - 241

JO - Sleep Medicine Clinics

JF - Sleep Medicine Clinics

SN - 1556-407X

IS - 2

ER -